ArticleFrontiers in oncology2026

Targeted therapy plus chemotherapy for advanced or metastatic triple-negative breast cancer: a PRISMA 2020 systematic review and meta-analysis.

Yanbing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.